Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Stock Forecast

Stock Price Forecast

The 16 analysts that cover Axsome Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $244, which forecasts a 9.60% increase in the stock price over the next year. The lowest target is $176 and the highest is $310.

Price Target: $244 (+9.60%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$176	$244	$255	$310
Change	-20.95%	+9.60%	+14.54%	+39.24%

Analyst Ratings

The average analyst rating for Axsome Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	9	9	7	7	7	7
Buy	11	11	10	9	9	8
Hold	0	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	20	21	18	17	17	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sean Laaman Morgan Stanley	Morgan Stanley	Hold Maintains $217 → $242	Hold	Maintains	$217 → $242	+8.70%	May 5, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $242 → $302	Buy	Maintains	$242 → $302	+35.65%	May 5, 2026
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Maintains $225 → $255	Buy	Maintains	$225 → $255	+14.54%	May 5, 2026
Yatin Suneja Guggenheim	Guggenheim	Strong Buy Maintains $245 → $260	Strong Buy	Maintains	$245 → $260	+16.79%	May 5, 2026
Graig Suvannavejh Mizuho	Mizuho	Buy Maintains $228 → $310	Buy	Maintains	$228 → $310	+39.24%	May 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.01B

Increased by 57.87%

from 638.50M

Revenue Next Year

1.59B

Increased by 57.44%

from 1.01B

EPS This Year

-0.77

from -3.68

EPS Next Year

6.81

from -0.77

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	50.04M	270.60M	385.69M	638.50M	1.01B	1.59B
Revenue Growth	-	-	440.80%	42.53%	65.55%	57.87%	57.44%
EPS	-3.47	-4.60	-5.27	-5.99	-3.68	-0.77	6.81
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	32.69
No. Analysts	-	-	-	-	-	22	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	1.1B	2.2B
Avg	1.0B	1.6B
Low	909.0M	1.2B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	69.8%	113.4%
Avg	57.9%	57.4%
Low	42.4%	19.4%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	1.36	15.46
Avg	-0.77	6.81
Low	-2.14	1.85

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.